Also from this source

You just read:

Complix Receives €0.5 Million Grant to Further Develop its Pipeline of Proprietary Cell Penetrating Alphabodies™ Against Intracellular Cancer Targets

News provided by

Complix

Dec 14, 2017, 02:00 EST